Abstract: Background and Purpose: Colorectal cancer (CRC) is a significant cause of morbidity and mortality worldwide, and screening is widely accepted as a means of improving outcomes. However, screening uptake remains low amongst Canadians aged 50-74. The study's objective was to obtain national-level baseline data regarding Canadians' attitudes towards and awareness of CRC screening.
INTRODUCTION
Colorectal cancer (CRC) is a significant cause of mortality and morbidity worldwide [1] [2] [3] [4] [5] . In Canada, an estimated 22,000 persons were diagnosed with CRC in 2009, over 9,000 deaths were attributed to it [6] , and it is the second leading cause of cancer death [7] . Early detection is considered the cornerstone of cancer control, and CRC screening is promoted as a means of reducing the burden of disease. Widespread screening for other forms of cancer (e.g. breast, cervical) is common place in most industrialized nations, and widely accepted as part of preventive health care [8] . Numerous international studies have demonstrated that CRC screening (by fecal occult blood testing, FOBT) for older adults has led to improvements in early detection and reduced morbidity and mortality [5, [9] [10] [11] [12] [13] . The Canadian Task Force on Preventive Health Care has recommended population screening for CRC since 2001 [14] . While a number of guidelines have been issued regarding CRC screening [14] [15] [16] [17] , it is generally recommended that persons at average risk for CRC aged 50 or older undergo FOBT biannually or endoscopic examination every 5 years [16, 18] . Colonoscopy is recommended for follow-up of positive FOBT [15] [16] [17] [18] . De-spite widespread acceptance of screening programs for other cancers, development of CRC screening guidelines, and considerable evidence supporting population-based screening for CRC, uptake remains lower than for other cancers in Canada and abroad [5, 12, 13] .
Numerous factors influencing CRC screening rates have been identified, including socioeconomic status (SES), insurance coverage, physician recommendation, ethnicity, knowledge, and health beliefs [3, 4, 19, 20] . Screening rates vary considerably between jurisdictions nationally and internationally [5] . We were interested in the role attitudes and awareness play in CRC screening uptake amongst Canadians. Prior studies in various jurisdictions indicate that attitudes (e.g. willingness to follow physician recommendation, embarrassment, fear) and awareness (e.g. of CRC risk factors, timing of screening) are important to screening uptake [21] [22] [23] [24] . None of these attitudinal and awareness factors has been looked at systematically in a large national survey in Canada. Our study sought to acquire national-level baseline data about Canadians' attitudes and awareness regarding CRC screening and their relationship to screening behaviours. Ultimately, these data are intended to inform future strategies to improve screening uptake among Canadians aged 50-74.
MATERIALS AND METHODOLOGY

Study Design
A telephone survey, commissioned by the Canadian Partnership Against Cancer, was designed and undertaken jointly by a survey research organization (Angus Reid Public Opinion, a division of Vision Critical) and a hospital-based academic research unit (Applied Health Research Centre, St. Michael's Hospital). The study was approved by an independent clinical research ethics review board (Canadian Shield Ethics Review Board).
Sampling and Recruitment
A modified random digit dialing (RDD) method 1 [25, 26] was used to identify a population-based sample of Canadians aged 45-74. The reason for including a subset of 45 to 49 year olds in addition to 50 to 74 year olds was because this younger cohort is fast approaching screening-eligible age and understanding their attitudes can inform the design of future interventions aimed at improving screening uptake. Telephone interviews were conducted in English and French between March 10 and April 17, 2009 using computerassisted technology. For each number selected, an initial call was placed and up to seven callbacks made.
Recruitment was stratified by province and territories. Within each province and the overall territories, quotas were set using 2006 Canadian Census data to ensure adequate representation across gender, age groups and community size [27] . One respondent was sampled per household. A total of 3,153 Canadians completed the survey. In total, 132,078 households were reached, 97,159 were disqualified because they did not meet the age or language requirements or were hearing impaired, and 31,766 refused to participate. Therefore, of those that qualified for the study, 9.0% agreed to participate. Final results were weighted within each province by age, gender and education and across provinces to the 45-74 year-old Canadian population [27] .
Data Collection Procedures
Survey content was informed by prior research [13, 28] , information from existing screening programs (provincially, internationally), and the collective experience of the project team. Survey topics included: attitudes towards cancer generally and CRC specifically; awareness and attitudes regarding cancer screening generally and CRC screening; prior screening participation (for CRC, other cancers); and whether individuals had discussed CRC screening with their doctors. Specific questions related to prior CRC screening participation were based on those of the Canadian Community Health Survey (CCHS) [28] 2 . The survey was pilot tested for clarity and length. Selected questions from the survey instrument appear in Table 1 .
Analysis
Data were weighted using 2006 Canadian Census estimates [27] . Provincial and overall territory data were weighted by age, gender and education to reflect the demographic composition within these areas. Data were also weighted across provinces and the territories to adjust for oversampling. All descriptive and regression analyses were conducted using the weighted sample. Comparisons between groups (e.g. men and women, age cohorts, SES groups) were made using the Chi-square test. For comparisons between provinces, we conducted logistic regression and used Bonferroni method to correct for multiple pair-wise comparisons. Multivariate logistic regression was conducted to examine factors predictive of prior CRC screening behaviours. All statistical analyses were performed using SAS Version 9.1 (SAS Institute, Cary, NC). All p-values were two-tailed and p-values < 0.05 were considered significant.
RESULTS
Demographic characteristics for the entire sample (n=3,153, respondents 45-74 years of age) appear in Table 2 . We sampled a subset of persons aged 45-49 because these persons are approaching screening age. Because persons aged 50-74 are the target population for screening, we emphasize the results from this cohort in this paper (n = 2,444). All results are weighted, therefore figures are reported as percentages only.
Attitudes and Awareness
The 50-74-year-old respondents demonstrated considerable experience with, and awareness of, cancer in general. For example, 93.4% (95% confidence interval (hereafter abbreviated as CI): 92.4-94.4%) indicated they had (45-74 yrs, old, n = 3,153) themselves. Most respondents who had never been diagnosed with cancer agreed that "you could do a lot to prevent getting cancer" (84.1%, CI: 82.7-85.5%) and that "cancer is something you survive and live with" (74.5%, CI: 72.8-76.2%), although 64.9% (CI: 63.0-66.8%) of these respondents reported being frightened by the prospect of developing cancer. Despite this, only 29.4% (CI: 27.6-31.2%) of respondents said they would prefer to not know they had cancer rather than being subjected to cancer treatments.
Most respondents were knowledgeable regarding specific CRC risk factors: three quarters knew that family history of CRC (76.8%, CI: 75.1-78.5%) and history of intestinal polyps (75.7%, CI: 74.0-77.4%) are considered risk factors. Despite this, 51.2% (CI: 49.2-53.2%) of respondents who had never been diagnosed with CRC stated they felt they knew very little about CRC. Focusing on attitudes towards CRC, 40.1% (CI: 38.2-42.0%) of those who had never had CRC agreed that CRC is "one of the worst kinds of cancer you can get", 92.5% (CI: 91.5-93.5%) felt that CRC could be treated successfully if caught early enough, and 41.2% (CI: 39.2-43.2%) indicated they were "very concerned" about developing the disease. Only 29.0% (CI: 27.2-30.8%) of respondents reported having discussed CRC screening with their doctor (Fig. 1) .
Survey respondents were asked about their understanding of cancer screening generally. Fully 90.1% (CI: 88.9-91.3%) of respondents understood that cancer screening is "a medical test performed to detect cancer" versus a "treatment for cancer" (5.1%, CI: 4.2-6.0%) or a "vaccination against cancer" (2.5%, CI: 1.9-3.1% Among respondents who reported never having been screened, the key reason offered was that they did not see a need to get tested because they felt fine/had no symptoms (49.3%, CI: 47.3-51.3%). Among respondents who indicated that they had been screened, the most commonly cited reason was that their "doctor told them to" (27.4%, CI: 25.6-29.2%). Focusing on attitudes toward CRC screening, only 11.0% (CI: 9.8-12.2%) of respondents agreed that they would be too embarrassed to discuss CRC testing with their doctor.
A majority (83.5%, CI: 82.0-85.0%) of 50-74 year-old respondents agreed that "people my age should get screened for CRC". Potentially unpleasant features of the test itself were not perceived as barriers to screening for most respondents. Only 27.5% (CI: 25.7-29.3%) indicated that the tests "gross them out", 27.5% (CI: 25.7-29.3%) were afraid that the tests would be painful, and 19.1% (CI: 17.5-20.7%) felt that the time and effort to prepare for tests was a deterrent. Despite these relatively positive attitudes, 56.1% (CI: 54.1-58.1%) indicated they worried receipt of a CRC diagnosis would result in colostomy.
Self-reported CRC Screening Behaviour
While the study's intention was to document Canadians' attitudes and awareness of CRC screening, we also sought data regarding self-reported screening behaviours. In terms of past screening participation, almost half of respondents had had at least one FOBT test previously (48.6%, CI: 46.6-50.6%), compared with 38.6% (CI: 36.7-40.5%) who had ever had colonoscopy or sigmoidoscopy. The overall proportion of people with up-to-date screening was 43.9% (CI: 41.9 -45.9) (FOBT in past 2 years, or colonoscopy/sigmoidoscopy in past 5 years). Specifically, 26.9% (CI: 25.1-28.7%) reported up-to-date FOBT, and 26.8% (CI: 25.0-28.6%) reported up-to-date colonoscopy/sigmoidoscopy. These data were important to understanding the relationship between screening behaviour, and attitudes and awareness.
Factors Predictive of CRC Screening Behaviour
Multivariate logistic regression identified factors associated with CRC screening behaviour. Table 3 depicts the factors most strongly associated with prior participation in CRC screening, listing odds ratios (OR) for each factor. Because of the study's focus on attitudinal and awareness factors, we primarily emphasize these results here. Having had discussions with one's doctor regarding CRC screening was the strongest predictor of screening participation. Respondents who recall such discussions were 6.81 (CI: 5.54-8.38) times more likely to have been screened for CRC than those who Fig. (1) . CRC Screening Discussions with Doctor. And those who agreed that getting tested would provide "peace of mind" were twice as likely to have been screened for CRC (OR 2.01, CI: 1.51-2.68, p < 0.001). Factors predictive of not engaging in screening were not recognizing the need to get tested in the absence of symptoms (OR 0.42, CI: 0.33-0.52, p < 0.001) and low self-rated knowledge of CRC screening (OR 0.56, CI: 0.46-0.67, p < 0.001).
DISCUSSION
This study provides, for the first time, national baseline data regarding Canadians' attitudes towards and awareness of CRC screening. It also provides important information on attitudinal and awareness factors associated with selfreported screening behaviours. We specifically focused on respondents 50 to 74 years old as they are the group targeted by provincial screening programs. Our results indicate that respondents were relatively aware of some features of CRC and were aware of colonoscopy. However only 42.8% had heard of FOBT and far fewer named it top of mind as a screening test for CRC. The findings will be informative to those designing interventions to improve screening uptake. The self-reported behaviours offered by our sample were similar to those described in the 2008 CCHS [18] . Some of our study's findings confirm those from other jurisdictions, while others demonstrate important differences. Similar to our respondents, Salkeld and colleagues (2003) found that 40% of their Australian survey respondents had heard of FOBT, while considerably more had heard of colonoscopy (79%) [32] . McCaffery's (2003) study in the United Kingdom demonstrated much lower levels of awareness of CRC risk factors, however they sampled individuals over a much wider age range (16-74 years of age) [3] .Other authors have identified the importance of family practitioners' roles in CRC screening uptake [2, 11, 20, [29] [30] [31] [32] . Here in Canada, Zarychanski and colleagues (2007) -and Wilkins and Shields (2009) -identified a positive relationship between frequency of self-reported contact with a family physician and participation in CRC screening [13, 18] , with similar findings reported by other investigators [7, 33] . An Ontario-based qualitative study identified recommendation by one's family doctor as the primary motivation for being tested amongst participants at average risk for CRC [33] . This same study included family physician participants, who indicated that they rarely performed CRC screening, and often only 'screen' in the presence of symptoms; these same family doctors expressed skepticism regarding the accuracy of FOBT and confusion regarding screening guidelines [33] . International studies have identified family practitioner recommendation as the factor most likely to encourage participation in CRC screening [11, [33] [34] [35] [36] . In Australia for example, 94% of respondents cited recommendation by their family doctor as the single strongest motivator for being screened, but unfortunately respondents were not asked whether they had indeed discussed it with their physicians [32] . Our results confirm that Canadians see recommendations by their family practitioners as primary motivators for engaging in screening, yet few are having these discussions with their doctors. While family physicians' skepticism regarding FOBT may partly explain this trend, a recent survey of Alberta physicians indicated that only 41.9% were familiar with CRC screening guidelines [37] . It is also possible that physician misperceptions of their patients' preferences for certain screening tests may be influencing doctors' willingness to recommend CRC screening tests, as has been found in American studies [11] .
The finding that Canadians did not report being overly embarrassed to discuss CRC screening with their doctors is encouraging. Recent studies from the United Kingdom identified embarrassment and fear of detecting cancer as the most frequently cited barriers to screening (and screening discussions) amongst both white and ethnic-minority Britons [4] . While we did not collect data regarding ethnicity, it would be useful to do so in future. Ethnicity appears to play a role in screening uptake. For example, a study of AsianAmerican minority groups demonstrated lower screening rates than Caucasian participants [12] . A study of urban African Americans suggest that knowledge and fear are important barriers to screening uptake by respondents [39] .
The prevalent misperception that screening occurs with the onset of symptoms is important. Authors in other jurisdictions (e.g. Australia, United States) have found an association between understanding the importance of screening in the absence of symptoms and intention to participate in screening in future [2, 38] . Such misperceptions regarding CRC screening may explain why so few people are discussing it with their doctors and why only a minority participate -patients may see it as unnecessary in the absence of symptoms. Thus interventions aimed at encouraging family physicians to initiate discussions regarding CRC screening with their patients may be the most effective approach to improving screening uptake.
Study Limitations
A stratified RDD sampling approach was used to help obtain a sample whose demographic profile was representative of the Canadian population between the ages of 45-74. Despite this, our investigation has a number of limitations. First, it employed telephone survey methodology, in which only those with household land lines were contacted. Those who use cellular phones exclusively (a growing segment of the population), and those without access to land lines (e.g. low income groups) were excluded [25] . It is difficult to assess the net impact of this bias. We suggest that future research be undertaken with these groups, to ensure their attitudes towards and awareness of colorectal cancer screening are understood and considered when planning public education initiatives.
The response rate for the survey was low (9.0%). However, we used a RDD approach and quotas and weighting to ensure the sample was reflective of the demographic profile of Canadians (45-75 years of age). Nevertheless, this raises the possibility of non-response bias. However the screening rates in our sample match those of the CHSS [28] (considered the 'gold standard' for health behaviour in Canada), suggesting that our sample was not 'unrepresentative'. When contacted, individuals were told that the survey focused on health issues (but neither cancer nor screening was mentioned initially). It is possible that survey participants were more interested and/or educated about health issues than those who chose not to participate.
CONCLUSION
This study provides for the first time important nationallevel baseline data regarding Canadians' attitudes towards and awareness of CRC and its screening, and identifies factors associated with screening behaviour. The findings suggest that Canadians need education about FOBT and the optimal timing for CRC screening (before symptom onset). In addition, designing interventions to support family physicians as key players in promoting CRC screening should be a priority. Because different provinces are at different stages of (and employ different strategies for) implementing population-based CRC screening programs, any interventions supporting family practitioners' roles should be tailored to meet provincial models of care. The study's findings can be used to inform policy makers, practitioners and cancer control agencies designing interventions to improve CRC screening uptake. It will allow those provinces with population-based screening programs already in place to gauge their performance over time, and to evaluate enhancements made to current programs.
